SK
Suresh Kumar Mishra
About Suresh Kumar Mishra
Data last updated:
Suresh Kumar Mishra is a Director at Gormanson Pharma Private Limited (since 2024) and Director at Wordsworth Consulton Private Limited (since 2024). The largest current company by reported revenue is Gormanson Pharma Private Limited at ₹15,678 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 11 Sep 2024 | 2024 | ₹15,678 (FY 2025) | Active | |
| Director | 22 Apr 2024 | 2024 | Active |
Board colleagues of Suresh Kumar Mishra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Harsh Mishra | 07558334 | Gormanson Pharma Private Limited , Wordsworth Consulton Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suresh Kumar Mishra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suresh Kumar Mishra
Suresh Kumar Mishra currently holds 2 directorships: Gormanson Pharma Private Limited (Director, since 11 Sep 2024, revenue ₹15,678 (FY 2025)); Wordsworth Consulton Private Limited (Director, since 22 Apr 2024).
Suresh Kumar Mishra was first appointed on 22 Apr 2024 as Director at Wordsworth Consulton Private Limited.
The current boards of Suresh Kumar Mishra's companies include Harsh Mishra (Gormanson Pharma Private Limited).